TipRanks
Turn Therapeutics Inc (TTRX)
NASDAQ:TTRX
US Market
Want to see TTRX full AI Analyst Report?

Turn Therapeutics Inc (TTRX) Drug Pipeline

30 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Vehicle, Gx-03
Atopic Dermatitis, Eczema, Eczema Atopic Dermatitis
Phase II
Recruiting
A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)
Jan 19, 2026
―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Turn Therapeutics Inc (TTRX) have in its pipeline
      TTRX is currently developing the following drugs: Vehicle, Gx-03. These drug candidates are in various stages of clinical development as the company works toward FDA approval.